XGN
EXAGEN INC.Company Information
- Company Name
- EXAGEN INC.
- CIK
- CIK0001274737
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- XGN: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- XGN
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-11-15
- Last sale
- 2026-09-01
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 101,579
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 7,407,609
- Shares outstanding
- 24,164,569
- Ownership
- 30.65%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- 14.57%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 25 | 22 | 32 | 36 | 30 | 11 | 22 | 22 | 24 | 27 | 36 | 28 | ||||||
| Accounts Receivable Net Current | 12 | 16 | 11 | 11 | 14 | 15 | 8 | 9 | 12 | 11 | 7 | 17 | ||||||
| Prepaid Expense And Other Assets Current | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 4 | 5 | 4 | 5 | 3 | ||||||
| Assets Current | 43 | 44 | 49 | 53 | 51 | 33 | 36 | 36 | 41 | 42 | 48 | 49 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 7 | 7 | 7 | 7 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 7 | ||||||
| Operating Lease Right Of Use Asset | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 52 | 52 | 58 | 63 | 59 | 40 | 45 | 44 | 49 | 51 | 57 | 61 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 4 | 4 | 4 | 3 | 5 | 4 | 1 | 2 | 1 | 3 | 2 | ||||||
| Accrued Liabilities Current | 5 | 5 | 6 | 6 | 5 | 5 | 7 | 6 | 6 | 6 | 8 | 7 | ||||||
| Contract With Customer Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | - | - | ||||||
| Finance Lease Liability Current | 1 | 1 | 1 | 1 | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Long Term Debt Current | 1 | 1 | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 13 | 13 | 14 | 13 | 10 | 14 | 14 | 9 | 9 | 9 | 12 | 10 | ||||||
| Long Term Debt Noncurrent | 22 | 22 | 22 | 22 | 22 | 18 | 20 | 20 | 20 | 19 | 19 | 19 | ||||||
| Finance Lease Liability Noncurrent | 2 | 2 | 2 | 2 | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 1 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 4 | ||||||
| Other Liabilities Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 40 | 38 | 41 | 45 | 38 | 34 | 35 | 31 | 32 | 31 | 34 | 33 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 334 | 333 | 332 | 328 | 324 | 304 | 304 | 303 | 303 | 303 | 302 | 301 | ||||||
| Retained Earnings Accumulated Deficit | -321 | -318 | -314 | -310 | -303 | -298 | -294 | -291 | -286 | -283 | -279 | -274 | ||||||
| Stockholders Equity | 12 | 14 | 17 | 18 | 21 | 6 | 10 | 13 | 18 | 20 | 23 | 28 | ||||||
| Liabilities And Stockholders Equity | 52 | 52 | 58 | 63 | 59 | 40 | 45 | 44 | 49 | 51 | 57 | 61 | ||||||
Preferred Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Common Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 24 | 24 | 23 | 23 | 22 | 18 | 18 | 18 | 17 | 17 | 17 | 17 | ||||||
| Shares Outstanding | 24 | 24 | 23 | 23 | 22 | 18 | 18 | 18 | 17 | 17 | 17 | 17 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEXAGEN INC. (XGN) — SEC Financial Statements & Analysis
EXAGEN INC. (XGN) is a services-medical laboratories company, incorporated in DE. EXAGEN INC. trades on Nasdaq as: XGN. EXAGEN INC. (XGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, EXAGEN INC. carries a market cap of $112.37M, a P/E ratio of -5.94x, a P/B ratio of 9.20x, a P/S ratio of 1.58x, an enterprise value of $111.51M, and an EV/EBITDA multiple of -8.44x. On profitability, it posts a gross margin of 58.64%, an operating margin of -18.58%, a net margin of -26.61%, a Return on Equity (ROE) of -113.82%, a Return on Assets (ROA) of -34.19%, and a Return on Invested Capital (ROIC) of -95.01%. Per share, it reports EPS of $-0.78, diluted EPS of $-0.78, free cash flow per share of $-0.31, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 20.83% year-over-year, net income growth of 11.44% year-over-year, and EPS growth of -2.76% year-over-year. On the balance sheet, it maintains a current ratio of 3.18x, a quick ratio of 2.75x, working capital of $29.40M, a debt-to-equity ratio of 3.25x, a debt ratio of 0.76, an interest coverage ratio of -2.58x, free cash flow of $-7.59M (TTM), and net debt of $-858.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $112.37M
- P/E TTM
- -5.94x
- EPS TTM
- $-0.78
- P/B TTM
- 9.20x
- ROE TTM
- -113.82%
- ROA TTM
- -34.19%
- Debt To Equity
- 3.25x
- Free Cash Flow TTM
- $-7.59M
- Net Revenue TTM Growth 1Y
- 20.83%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is EXAGEN INC. in?
EXAGEN INC. (XGN) operates in the Services-Medical Laboratories industry.
What exchange does XGN trade on?
EXAGEN INC. (XGN) trades on the Nasdaq.
Where is EXAGEN INC. incorporated?
EXAGEN INC. is incorporated in DE.
When was EXAGEN INC. (XGN)'s most recent SEC filing?
EXAGEN INC. (XGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is XGN's market cap?
EXAGEN INC. (XGN) has a market capitalization of $112.37M as of 2026-06-30.
What is XGN's EPS (earnings per share)?
EXAGEN INC. (XGN)'s trailing twelve month EPS is $-0.78 as of 2026-06-30.
What is XGN's ROE (return on equity)?
EXAGEN INC. (XGN)'s trailing twelve month Return on Equity (ROE) is -113.82% as of 2026-06-30.
What is XGN's ROA (return on assets)?
EXAGEN INC. (XGN)'s trailing twelve month Return on Assets (ROA) is -34.19% as of 2026-06-30.
What is XGN's ROIC (return on invested capital)?
EXAGEN INC. (XGN)'s trailing twelve month Return on Invested Capital (ROIC) is -95.01% as of 2026-06-30.
What is XGN's EV/EBITDA?
EXAGEN INC. (XGN)'s trailing twelve month EV/EBITDA is -8.44x as of 2026-06-30.